ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,388.15
0.41%
Dow Jones
39,056.39
0.00%
Gold vs US Dollar
2,312.68
0.20%
Brent Oil
83.915
0.42%
Bitcoin
61,068.93
-0.19%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vaccinex Inc (VCNX)

  7. Vaccinex Inc (VCNX) News

Vaccinex (VCNX)

Vaccinex Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VCNX
DateTimeSourceHeadlineSymbolCompany
08/05/202417:29Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:VCNXVaccinex Inc
02/04/202413:30GlobeNewswire Inc.Vaccinex Reports 2023 Financial Results and Provides Corporate UpdateNASDAQ:VCNXVaccinex Inc
27/03/202412:30GlobeNewswire Inc.Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:VCNXVaccinex Inc
04/03/202421:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
21/02/202415:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
21/02/202413:00GlobeNewswire Inc.Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus TechnologyNASDAQ:VCNXVaccinex Inc
15/02/202413:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
15/02/202413:00GlobeNewswire Inc.Vaccinex, Inc. Announces Reverse Stock SplitNASDAQ:VCNXVaccinex Inc
13/02/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
13/02/202421:15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:VCNXVaccinex Inc
12/02/202421:22Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:VCNXVaccinex Inc
09/02/202421:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
09/02/202421:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
09/02/202421:08Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VCNXVaccinex Inc
08/02/202413:20Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VCNXVaccinex Inc
07/02/202420:43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
07/02/202413:00GlobeNewswire Inc.Vaccinex Announces Pricing of $3.7 Million PIPE FinancingNASDAQ:VCNXVaccinex Inc
22/01/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VCNXVaccinex Inc
19/01/202421:40Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VCNXVaccinex Inc
10/01/202422:16Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VCNXVaccinex Inc
08/01/202421:16Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VCNXVaccinex Inc
28/12/202321:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
28/12/202321:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VCNXVaccinex Inc
12/12/202321:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
04/12/202313:00GlobeNewswire Inc.Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing RuleNASDAQ:VCNXVaccinex Inc
13/11/202313:00GlobeNewswire Inc.Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:VCNXVaccinex Inc
13/11/202312:46Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VCNXVaccinex Inc
03/11/202320:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
31/10/202313:00GlobeNewswire Inc.Vaccinex Reports Clinical Benefit in Interim Analyses from two Phase 2 Studies of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual MeetingNASDAQ:VCNXVaccinex Inc
26/10/202314:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
 Showing the most relevant articles for your search:NASDAQ:VCNX

Your Recent History

LSE
POS
Plexus
LSE
TERN
Tern
LSE
KEFI
Kefi Gold And Copper
LSE
GOLD
LSE
ITV
Itv
LSE
BIRD
Blackbird
LSE
SCE
Surface Transforms
LSE
GWMO
Great Western Mining
LSE
SYME
Supply@me Capital
LSE
PET
Petrel Resources
LSE
TYM
Tertiary Minerals
LSE
LLOY
Lloyds Banking
LSE
DEC
Diversified Energy
LSE
FDEV
Frontier Developments
LSE
AAU
Ariana Resources
LSE
LND
Landore Resources
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved